Skip to content

Author

Christina Gallo-Ebert

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

The monoacylglycerol acyltransferase 2 inhibitor VB-85387 reduces MASLD

Metabolic dysfunction-associated steatotic liver disease (MASLD) arises from the accumulation of triglycerides within the liver. MASLD can advance to metabolic dysfunction-associated steatohepatitis (MASH), cirrhosis, and hepatocellular carcinoma. Monoacylglycerol acyltransferase 2 (MOGAT2) is essential for triglycerid...

Christina Gallo-Ebert, J. Wayne, Alyssa Brown et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.